PHARMACYCLICS, INC.

Market Report, "Pharmacyclics, Inc. - Product Pipeline Review - 2013", published

Pre-Market Analysis on STSI, IPXL, PCYC, and UTHR (NAS,NAS,NAS,NAS:STSI,IPXL,PCYC,UTHR)

2013 FDA Drug Approval Calendar

Pharmacyclics drug designated for orphan status for multiple myeloma treatment

Janssen Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data

10 ASCO '13 Abstracts You Can Read Right Now

3 Biotech Stocks Spiking With Big Volume

RBC Capital Upgrades Pharmacyclics (PCYC) to Outperform

Pharmacyclics upgraded to Outperform from Sector Perform at RBC Capital

6 Superstars For Your Biotech Portfolio: John McCamant